BioCardia Announces FDA Market Clearance of Morph® DNA™ Steerable Introducer Product Family
29 août 2024 08h30 HE
|
BioCardia, Inc.
SUNNYVALE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...